A DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, ESCALATING MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY AND PHARMACOKINETICS OF TV-1380 IN HEALTHY VOLUNTEERS
Completed
- Conditions
- Cocaineverslaving en cocaine-overdosisCocaine addiction
- Registration Number
- NL-OMON35366
- Lead Sponsor
- TEVA Pharma
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 33
Inclusion Criteria
Healthy male and female volunteers, 18-45 years of age, BMI between 18.0 and 30.0 kg/m2; weight is at least 50 kg, no smokers for at least 3 months
Exclusion Criteria
Suffering from: hepatitis B, cancer or HIV/AIDS. In case of participation in another drug study within 60 days before the start of this study or being a blood donor within 90 days from the start of the study. In case of donating more than 1.5 liters of blood in the 10 months prior the start of this study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method